Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma
![Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. - Abstract - Europe PMC Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6071274/bin/cancers-10-00240-g001.jpg)
Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. - Abstract - Europe PMC
Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma
![Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. - Abstract - Europe PMC Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6071274/bin/cancers-10-00240-g003.jpg)
Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. - Abstract - Europe PMC
Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma
![Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma](https://ndownloader.figstatic.com/files/13490342/preview/13490342/preview.jpg)
Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma
Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma
![Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting | Gene Therapy Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting | Gene Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.gt.3301493/MediaObjects/41434_2001_Article_BF3301493_Fig4_HTML.jpg)
Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting | Gene Therapy
The Newly Discovered Cytokine IL-34 Is Expressed in Gingival Fibroblasts, Shows Enhanced Expression by Pro-Inflammatory Cytokines, and Stimulates Osteoclast Differentiation
The Newly Discovered Cytokine IL-34 Is Expressed in Gingival Fibroblasts, Shows Enhanced Expression by Pro-Inflammatory Cytokines, and Stimulates Osteoclast Differentiation
The Newly Discovered Cytokine IL-34 Is Expressed in Gingival Fibroblasts, Shows Enhanced Expression by Pro-Inflammatory Cytokines, and Stimulates Osteoclast Differentiation
Understanding the pathophysiological actions of tau oligomers : a critical review of current electrophysiological methods - WRAP: Warwick Research Archive Portal
![Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting | Gene Therapy Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting | Gene Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.gt.3301493/MediaObjects/41434_2001_Article_BF3301493_Fig1_HTML.jpg)